The Positive Allosteric Modulator of Alpha‐2/3‐Containing γ‐Aminobutyric Acid Type A Receptors, KRM‐II‐81, Is Active in Pharmacoresistant Models of Epilepsy and in Human Epileptic Tissue. (September 2019)